Login to Your Account



Financings Roundup

Gelesis Closes $16M Series A to Fund its Obesity Program

By Trista Morrison


Friday, January 4, 2008

No Abstract

 

Staff Writer

With plans to target the ballooning obesity market, Gelesis Inc. raised $16 million in its Series A financing.

The Boston-based company has remained under the radar since its founding in 2006, and Eric Elenko, interim vice president of business development, declined to comment on its technology or pipeline.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription